CI Investments Inc’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $342M | Sell |
371,515
-22,269
| -6% | -$22.6M | 1.66% | 10 |
|
|
2025
Q4 | $423M | Buy |
393,784
+57,497
| +17% | +$55M | 1.85% | 10 |
|
|
2025
Q3 | $257M | Sell |
336,287
-7,599
| -2% | -$5.65M | 0.93% | 17 |
|
|
2025
Q2 | $268M | Sell |
343,886
-89,515
| -21% | -$69.6M | 1.01% | 13 |
|
|
2025
Q1 | $358M | Sell |
433,401
-31,769
| -7% | -$26.4M | 1.51% | 10 |
|
|
2024
Q4 | $359M | Buy |
465,170
+4,109
| +0.9% | +$3.4M | 1.35% | 11 |
|
|
2024
Q3 | $408M | Sell |
461,061
-84,019
| -15% | -$75.5M | 1.55% | 10 |
|
|
2024
Q2 | $494M | Buy |
545,080
+3,353
| +0.6% | +$2.68M | 1.94% | 9 |
|
|
2024
Q1 | $421M | Sell |
541,727
-29,353
| -5% | -$20.9M | 1.67% | 9 |
|
|
2023
Q4 | $333M | Sell |
571,080
-298,286
| -34% | -$174M | 1.72% | 10 |
|
|
2023
Q3 | $467M | Sell |
869,366
-30,401
| -3% | -$15.7M | 2.61% | 6 |
|
|
2023
Q2 | $422M | Buy |
899,767
+153,023
| +20% | +$64.2M | 2.13% | 7 |
|
|
2023
Q1 | $256M | Buy |
746,744
+85,219
| +13% | +$28.7M | 1.29% | 16 |
|
|
2022
Q4 | $242M | Buy |
661,525
+173,954
| +36% | +$61.7M | 1.22% | 20 |
|
|
2022
Q3 | $158M | Buy |
487,571
+129,677
| +36% | +$41.1M | 0.82% | 32 |
|
|
2022
Q2 | $116M | Sell |
357,894
-67,861
| -16% | -$20.4M | 0.54% | 49 |
|
|
2022
Q1 | $122M | Buy |
425,755
+72,152
| +20% | +$18.6M | 0.45% | 60 |
|
|
2021
Q4 | $97.7M | Sell |
353,603
-59,315
| -14% | -$15M | 0.34% | 81 |
|
|
2021
Q3 | $95.4M | Buy |
412,918
+330,106
| +399% | +$81.5M | 0.36% | 81 |
|
|
2021
Q2 | $19M | Buy |
82,812
+3,336
| +4% | +$670K | 0.07% | 227 |
|
|
2021
Q1 | $14.8M | Sell |
79,476
-155,974
| -66% | -$30.5M | 0.06% | 226 |
|
|
2020
Q4 | $39.8M | Sell |
235,450
-291,822
| -55% | -$43.6M | 0.18% | 142 |
|
|
2020
Q3 | $78M | Buy |
527,272
+134,154
| +34% | +$20.8M | 0.39% | 72 |
|
|
2020
Q2 | $64.5M | Sell |
393,118
-140,180
| -26% | -$21.5M | 0.34% | 81 |
|
|
2020
Q1 | $74M | Sell |
533,298
-121,493
| -19% | -$16.7M | 0.45% | 66 |
|
|
2019
Q4 | $86.1M | Buy |
654,791
+588,252
| +884% | +$68.2M | 0.44% | 73 |
|
|
2019
Q3 | $7.44M | Buy |
+66,539
| New | +$7.41M | 0.04% | 229 |
|
|
2019
Q1 | – | Sell |
-1,200
| Closed | -$139K | – | 353 |
|
|
2018
Q4 | $139K | Buy |
+1,200
| New | +$134K | ﹤0.01% | 298 |
|
|
2013
Q3 | – | Sell |
-2,848,473
| Closed | -$140M | – | 192 |
|
|
2013
Q2 | $140M | Buy |
+2,848,473
| New | +$155M | 1.52% | 17 |
|
Other funds holding LLY
VCM
VPM
CI Investments Inc's LLY Position: Q1 2026 in Review
CI Investments Inc reduced its Eli Lilly (LLY) stake by 5.7% in Q1 2026, selling an estimated $22.6M and leaving 371,515 shares worth $342M. The position accounts for 1.66% of the portfolio, ranked #10.
CI Investments Inc first reported a position in LLY in Q2 2013 and has held it in 29 quarters since. The position peaked at $494M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- CI Investments Inc held 371,515 shares of Eli Lilly worth $342M as of Q1 2026.
- CI Investments Inc sold 22,269 Eli Lilly shares in Q1 2026, an estimated $22.6M.
- Eli Lilly made up 1.66% of CI Investments Inc's portfolio in Q1 2026, its #10 holding.
- CI Investments Inc first reported a position in Eli Lilly in Q2 2013 and has held it in 29 quarters since.
- CI Investments Inc's Eli Lilly position peaked at $494M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.